Quantcast
Are you getting the best rate from your broker?
Compare your broker's rates now to find out if you can save money

Choose your broker below
Welcome to Dividend.com. Please help us personalize your experience.

Select the one that best describes you
Dividend logo

When investors think of biotech stocks, the word “lottery” comes to mind. And for the most part, they are right. The vast bulk of the sector made up of smaller, early-stage drug developers with only one, or maybe two, new therapies in development. These firms live or die by how one drug performs. Fail the first round of a clinical trial and the stock is done for. Make it past the FDA’s watch and the stock soars.

A “lottery ticket” is certainly an accurate comparison when it comes to investing in biotech.

To read the Full Story, Go Premium or Log In

Popular Articles

Premium Untitled%20design%20%2815%29
News

Do We Still Need Stimulus?

The global credit crisis and worldwide recession was one of the worst economic disasters to...

Premium Untitled%20design%20%2816%29
News

Healthcare REITs’ Prognosis Is Great

For the commercial real estate sector, the last few months haven’t exactly been booming. Thanks...

News

Philip Morris International Inc: Will Smokeless Tobacco Save the Cigarette Industry?

Philip Morris International Inc. (PM ) is a holding company that was originally part of the...